Cargando…
RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer
Radiation therapy is a common and acceptable approach for lung cancer. Although the benefit of ionizing radiation (IR) is well-established, cancer cells can still survive via pro-survival and metastasis signaling pathways. Ras related C3 botulinum toxin substrate1 (RAC1), a member of Rho family GTPa...
Autores principales: | Tan, Shiming, Yi, Pin, Wang, Heran, Xia, Longzheng, Han, Yaqian, Wang, Hui, Zeng, Biao, Tang, Lu, Pan, Qing, Tian, Yutong, Rao, Shan, Oyang, Linda, Liang, Jiaxin, Lin, Jinguan, Su, Min, Shi, Yingrui, Liao, Qianjin, Zhou, Yujuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198748/ https://www.ncbi.nlm.nih.gov/pubmed/32411607 http://dx.doi.org/10.3389/fonc.2020.00649 |
Ejemplares similares
-
Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer
por: Tan, Shiming, et al.
Publicado: (2020) -
Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition
por: Xia, Longzheng, et al.
Publicado: (2019) -
Rac1, A Potential Target for Tumor Therapy
por: Liang, Jiaxin, et al.
Publicado: (2021) -
Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer
por: Zhou, Yujuan, et al.
Publicado: (2016) -
Exosomal miRNAs in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2020)